{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:56:07Z","timestamp":1791820567422,"version":"4.3.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T00:00:00Z","timestamp":1685664000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T00:00:00Z","timestamp":1685664000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["543002006"],"award-info":[{"award-number":["543002006"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Primary carnitine deficiency is an inborn error of metabolism, which can lead to life-threating complications early in life. Low carnitine levels can be detected by newborn bloodspot screening (NBS). However, NBS can also identify, mostly asymptomatic, mothers with primary carnitine deficiency. To identify mothers\u2019 needs and areas for improving screening practice, this study explored the experiences with, and opinions on primary carnitine deficiency screening in NBS among women diagnosed through NBS of their newborn.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Twelve Dutch women were interviewed, 3\u201311 years after diagnosis. Data were analysed using a thematic approach.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Four main themes were derived: 1)\u00a0psychological impact of primary carnitine deficiency diagnosis, 2)\u00a0becoming a patient and \u201cpatient-in-waiting\u201d, 3)\u00a0information issues and care provision, and 4)\u00a0primary carnitine deficiency as part of the NBS panel. Mothers shared that they did not experience major psychological distress of the diagnosis. They did experience (recall) various emotions following the initial abnormal NBS result, including fear and anxiety as well as relief, and emotions regarding their own diagnosis, including uncertainty about health risks and treatment effectiveness. Some felt a patient-in-waiting. Many participants experienced a lack of information, especially shortly after receiving the abnormal NBS result. All shared the belief that screening for primary carnitine deficiency in NBS is beneficial for the newborn, and, given the information they received, also considered the knowledge beneficial for their own health.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Psychological burden following diagnosis was experienced by women as limited, although the experienced lack of information amplified feelings of uncertainty and anxiety. Most mothers believed that benefits of knowing about primary carnitine deficiency outweighed the disadvantages. Mothers\u2019 perspectives should be incorporated in policy-making about primary carnitine deficiency in NBS.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-023-02735-0","type":"journal-article","created":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T12:52:49Z","timestamp":1685710369000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A qualitative study on the perspectives of mothers who had been diagnosed with primary carnitine deficiency through newborn screening of their child"],"prefix":"10.1186","volume":"18","author":[{"given":"Lieke M.","family":"van den Heuvel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Kater-Kuipers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tessa","family":"van Dijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loek L.","family":"Crefcoeur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gepke","family":"Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam","family":"Langeveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3531-0597","authenticated-orcid":false,"given":"Lidewij","family":"Henneman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,2]]},"reference":[{"issue":"1","key":"2735_CR1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/ijns9010006","volume":"9","author":"CR Lef\u00e8vre","year":"2023","unstructured":"Lef\u00e8vre CR, Labarthe F, Dufour D, Moreau C, Faoucher M, Rollier P, et al. Newborn screening of primary carnitine deficiency: an overview of worldwide practices and pitfalls to define an algorithm before expansion of newborn screening in France. Int J Neonat Screen. 2023;9(1):6.","journal-title":"Int J Neonat Screen"},{"issue":"1","key":"2735_CR2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/5030","volume":"21","author":"J Nezu","year":"1999","unstructured":"Nezu J, Tamai I, Oku A, Ohashi R, Yabuuchi H, Hashimoto N, et al. Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter. Nat Genet. 1999;21(1):91\u20134.","journal-title":"Nat Genet"},{"key":"2735_CR3","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/1750-1172-7-68","volume":"7","author":"PL Magoulas","year":"2012","unstructured":"Magoulas PL, El-Hattab AW. Systemic primary carnitine deficiency: an overview of clinical manifestations, diagnosis, and management. Orphanet J Rare Dis. 2012;7:68.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"2735_CR4","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ymgme.2009.12.015","volume":"100","author":"N-C Lee","year":"2010","unstructured":"Lee N-C, Tang NL-S, Chien Y-H, Chen C-A, Lin S-J, Chiu P-C, et al. Diagnoses of newborns and mothers with carnitine uptake defects through newborn screening. Mol Genet Metab. 2010;100(1):46\u201350.","journal-title":"Mol Genet Metab"},{"issue":"1","key":"2735_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/GIM.0b013e3181c5e6f7","volume":"12","author":"AW El-Hattab","year":"2010","unstructured":"El-Hattab AW, Li FY, Shen J, Powell BR, Bawle EV, Adams DJ, et al. Maternal systemic primary carnitine deficiency uncovered by newborn screening: clinical, biochemical, and molecular aspects. Genet Med. 2010;12(1):19\u201324.","journal-title":"Genet Med"},{"issue":"1","key":"2735_CR6","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/jimd.12030","volume":"42","author":"C Wilson","year":"2019","unstructured":"Wilson C, Knoll D, de Hora M, Kyle C, Glamuzina E, Webster D. The decision to discontinue screening for carnitine uptake disorder in New Zealand. J Inherit Metab Dis. 2019;42(1):86\u201392.","journal-title":"J Inherit Metab Dis"},{"key":"2735_CR7","unstructured":"Health Council of the Netherlands. Neonatal screening: new recommendations. The Hague; 2015. Publication no. 2015\/08E."},{"key":"2735_CR8","volume-title":"Principles and practice of screening for disease","author":"JMG Wilson","year":"1968","unstructured":"Wilson JMG, Jungner G. Principles and practice of screening for disease. Geneva: World Health Organisation; 1968."},{"issue":"2","key":"2735_CR9","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s12687-020-00488-y","volume":"12","author":"MC Cornel","year":"2021","unstructured":"Cornel MC, Rigter T, Jansen ME, Henneman L. Neonatal and carrier screening for rare diseases: how innovation challenges screening criteria worldwide. J Community Genet. 2021;12(2):257\u201365.","journal-title":"J Community Genet"},{"issue":"3","key":"2735_CR10","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/jimd.12475","volume":"45","author":"LL Crefcoeur","year":"2022","unstructured":"Crefcoeur LL, Visser G, Ferdinandusse S, Wijburg FA, Langeveld M, Sjouke B. Clinical characteristics of primary carnitine deficiency: a structured review using a case-by-case approach. J Inherit Metab Dis. 2022;45(3):386\u2013405.","journal-title":"J Inherit Metab Dis"},{"key":"2735_CR11","doi-asserted-by":"publisher","first-page":"100776","DOI":"10.1016\/j.ymgmr.2021.100776","volume":"28","author":"KA Schiergens","year":"2021","unstructured":"Schiergens KA, Weiss KJ, Roschinger W, Lotz-Havla AS, Schmitt J, Dalla Pozza R, et al. Newborn screening for carnitine transporter defect in Bavaria and the long-term follow-up of the identified newborns and mothers: assessing the benefit and possible harm based on 19 1\/2 years of experience. Mol Genet Metab Rep. 2021;28:100776.","journal-title":"Mol Genet Metab Rep"},{"key":"2735_CR12","volume-title":"The newborn blood spot screening in the Netherlands - Monitor 2021","author":"CPB van der Ploeg","year":"2023","unstructured":"van der Ploeg CPB, van der Mast O, Eekhout I, Verkerk PH. The newborn blood spot screening in the Netherlands - Monitor 2021. Leiden: TNO and RIVM; 2023. Publication no. R10134."},{"issue":"2","key":"2735_CR13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Clarke","year":"2006","unstructured":"Clarke V, Braun V. Using thematic analysis in psychology. Qualitative Res Psychol. 2006;3(2):77\u2013101.","journal-title":"Qualitative Res Psychol"},{"issue":"6","key":"2735_CR14","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","volume":"19","author":"A Tong","year":"2007","unstructured":"Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349\u201357.","journal-title":"Int J Qual Health Care"},{"issue":"4","key":"2735_CR15","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3390\/ijns8040053","volume":"8","author":"A Tluczek","year":"2022","unstructured":"Tluczek A, Ersig AL, Lee S. Psychosocial issues related to newborn screening: a systematic review and synthesis. Int J Neonat Screen. 2022;8(4):53.","journal-title":"Int J Neonat Screen"},{"issue":"4","key":"2735_CR16","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1177\/0022146510386794","volume":"51","author":"S Timmermans","year":"2010","unstructured":"Timmermans S, Buchbinder M. Patients-in-waiting: living between sickness and health in the genomics era. J Health Soc Behav. 2010;51(4):408\u201323.","journal-title":"J Health Soc Behav"},{"issue":"1","key":"2735_CR17","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s10875-020-00886-4","volume":"41","author":"M Blom","year":"2021","unstructured":"Blom M, Bredius RGM, Jansen ME, Weijman G, Kemper EA, Vermont CL, et al. Parents\u2019 perspectives and societal acceptance of implementation of newborn screening for SCID in the Netherlands. J Clin Immunol. 2021;41(1):99\u2013108.","journal-title":"J Clin Immunol"},{"issue":"1","key":"2735_CR18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1542\/peds.2010-3413","volume":"128","author":"JM DeLuca","year":"2011","unstructured":"DeLuca JM, Kearney MH, Norton SA, Arnold GL. Parents\u2019 experiences of expanded newborn screening evaluations. Pediatrics. 2011;128(1):53\u201361.","journal-title":"Pediatrics"},{"key":"2735_CR19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jpeds.2020.03.027","volume":"224","author":"MH Farrell","year":"2020","unstructured":"Farrell MH, La Pean Kirschner A, Tluczek A, Farrell PM. Experience with parent follow-up for communication outcomes after newborn screening identifies carrier status. J Pediatr. 2020;224:37\u201343. e2.","journal-title":"J Pediatr"},{"key":"2735_CR20","doi-asserted-by":"publisher","first-page":"706394","DOI":"10.3389\/fped.2021.706394","volume":"9","author":"T van Dijk","year":"2021","unstructured":"van Dijk T, Kater A, Jansen M, Dondorp WJ, Blom M, Kemp S, et al. Expanding neonatal bloodspot screening: a multi-stakeholder perspective. Front Pediatr. 2021;9:706394.","journal-title":"Front Pediatr"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-02735-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-023-02735-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-02735-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T12:56:54Z","timestamp":1685710614000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-023-02735-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,2]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2735"],"URL":"https:\/\/doi.org\/10.1186\/s13023-023-02735-0","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,2]]},"assertion":[{"value":"9 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Medical Ethical Committee of Amsterdam UMC location VU University Medical Center reviewed the study protocol and concluded that the Dutch Act of Medical Research Involving Human Subjects (WMO) was not applicable (METC No. 2019\u2009\u2212\u2009509). All participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"134"}}